Urinary mycoestrogens and gestational weight gain in the UPSIDE pregnancy cohort

Table 3 Spearman correlation between log-transformed specific-gravity adjusted urinary mycoestrogen concentrations (ng/ml), dietary parameters, and gestational weight gain (n = 253)^a

	ZEN	aZOL	Σmyco	BMI	Energy intake	HEI-2015	UPF%	GWG rate	Total GWG
ZEN	-	0.80	0.90	-0.05	-0.04	-0.08	0.12	0.09	0.10
aZOL	0.80	-	0.87	0.06	-0.01	-0.10	0.11	-0.01	-0.01
Σmyco	0.90	0.87	-	0.02	-0.01	-0.15	0.14	0.01	0.02
BMI	-0.05	0.06	0.02	-	-0.26	-0.26	0.15	-0.39	-0.39
Energy Intake	-0.04	-0.01	-0.01	-0.26	-	-0.10	0.06	0.17	0.17
HEI-2015	-0.08	-0.10	0.14	-0.26	-0.10	-	-0.38	0.19	0.18
UPF%	0.12	0.11	0.02	0.15	0.06	-0.38	-	-0.11	-0.10
GWG Rate	0.09	-0.01	0.01	-0.39	0.17	0.18	-0.10	-	0.98
Total GWG	0.10	-0.01	0.02	-0.39	0.17	0.19	-0.11	0.98	-

Abbreviations: aZOL alpha-zearalenol, Energy Intake kilocalories/day, HEI-2015 Healthy Eating Index, GWG rate Average weekly gain across pregnancy, UPF% Ultra-processed foods, Σmyco sum of mycoestrogen analytes, Total GWG Total gestational weight gain, ZEN Zearalenone
^aThe n represents participants who contributed dietary information and mycoestrogen data at least one time during pregnancy. Values below LOD were replaced with LOD/√2. Bold indicates significance at p < 0.05

ISSN: 1476-069X